As of 2025-07-14, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is - USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.70 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-07-10 | -10.91 |
| 2025-07-09 | -10.57 |
| 2025-07-08 | -9.54 |
| 2025-07-07 | -9.69 |
| 2025-07-03 | -9.54 |
| 2025-07-02 | -9.26 |
| 2025-07-01 | -8.94 |
| 2025-06-30 | -8.92 |
| 2025-06-27 | -9.15 |
| 2025-06-26 | -9.65 |
| 2025-06-25 | -9.40 |
| 2025-06-24 | -9.37 |
| 2025-06-23 | -9.55 |
| 2025-06-20 | -9.01 |
| 2025-06-18 | -9.47 |
| 2025-06-17 | -9.04 |
| 2025-06-16 | -9.40 |
| 2025-06-13 | -9.54 |
| 2025-06-12 | -9.88 |
| 2025-06-11 | -9.87 |
| 2025-06-10 | -9.92 |
| 2025-06-09 | -9.67 |
| 2025-06-06 | -9.91 |
| 2025-06-05 | -9.26 |
| 2025-06-04 | -9.17 |
| 2025-06-03 | -8.92 |
| 2025-06-02 | -8.58 |
| 2025-05-30 | -8.25 |
| 2025-05-29 | -8.56 |
| 2025-05-28 | -8.30 |
| 2025-05-27 | -8.15 |
| 2025-05-23 | -8.16 |
| 2025-05-22 | -8.36 |
| 2025-05-21 | -8.29 |
| 2025-05-20 | -8.97 |
| 2025-05-19 | -8.86 |
| 2025-05-16 | -8.69 |
| 2025-05-15 | -8.64 |
| 2025-05-14 | -8.71 |
| 2025-05-13 | -8.77 |
| 2025-05-12 | -9.06 |
| 2025-05-09 | -9.04 |
| 2025-05-08 | -8.97 |
| 2025-05-07 | -8.91 |
| 2025-05-06 | -8.80 |
| 2025-05-05 | -10.61 |
| 2025-05-02 | -11.11 |
| 2025-05-01 | -10.89 |
| 2025-04-30 | -10.59 |
| 2025-04-29 | -10.07 |